B&G Bewegungstherapie und Gesundheitssport 2009; 25(4): 158-161
DOI: 10.1055/s-0029-1224538
WISSENSCHAFT

© Hippokrates Verlag in MVS Medizinverlage Stuttgart GmbH & Co. KG

Knochenbrüche im Kindes- und Jugendalter – ein Hinweis auf Osteoporose?

R. Beccard1 , C. Land2
  • 1Klinik und Poliklinik für Kinderheilkunde, Universität zu Köln
  • 2Endokrinologikum München, Zentrum für Hormon- und Stoffwechselerkrankungen, München
Further Information

Publication History

Publication Date:
12 August 2009 (online)

Osteoporose wird zunehmend auch als ein pädiatrisches Problem bei Kindern und Jugendlichen mit genetischen und chronischen Erkrankungen wahrgenommen, in dessen Folge typischerweise klinisch bedeutsame Frakturen auftreten. Ziel dieses Reviews ist, einen Überblick über die mit der Osteoporose verbundenen Probleme bezüglich Diagnose und Therapie der betroffenen Kinder und Jugendlichen zu geben. Während der letzten Dekade wurden Fortschritte in Bezug auf die Identifizierung von Kindern und Jugendlichen mit Osteoporose erzielt. In den Vordergrund rücken nun Fragen nach wirksamen Strategien zur Früherkennung von Kindern und Jugendlichen, die für die Entwicklung einer Osteoporose ein Risiko aufweisen. Das würde die Möglichkeit frühzeitiger präventiver und therapeutischer Maßnahmen eröffnen. In diesem Review werden die Veränderungen der Knochen während des Wachstums und Probleme der Knochendichtemessung bei Kindern und Jugendlichen beschrieben sowie neue Strategien zur Frakturvorhersage vorgestellt. Abschließend wird der aktuelle Stand der medikamentösen Therapie diskutiert.

Abstract

Osteoporosis is increasingly recognized as an important paediatric problem in children and adolescents with genetic disorders and chronic diseases – with the consequence of clinically significant fractures. Goal of this review is to provide an overview of the scope of the problems, highlighting the unique issues that arise from the diagnosis and treatment in children and adolescents. While the past decade has seen progress in the identification of pediatric osteoporosis, there is ongoing need to develop new strategies for fracture prediction in order to primarily identify children at risk of clinically relevant fractures. These approaches would allow early intervention strategies. The purpose of this review is to describe changes in bone with growth, to discuss some problems of bone mineral density measurements, and to review recent attempts to provide new fracture prediction strategies in children and adolescents. In addition, current medical therapies are discussed.

Literatur

  • 1 Albright J A. Systemic treatment of osteogenesis imperfecta.  Clin Orthop Relat Res. 1981;  88-96
  • 2 Astrom E, Soderhall S. Beneficial effect of long term intravenous bisphosphonate treatment of osteogenesis imperfecta.  Arch Dis Child. 2002;  86 356-364
  • 3 Bailey D A, Wedge J H, McCulloch R G et al. Epidemiology of fractures of the distal end of the radius in children as associated with growth.  J Bone Joint Surg Am. 1989;  71 1225-1231
  • 4 Bishop N, Braillon P, Burnham J et al. Dual-energy X-ray aborptiometry assessment in children and adolescents with diseases that may affect the skeleton: the 2007 ISCD Pediatric Official Positions.  J Clin Densitom. 2008;  11 29-42
  • 5 Clark E M, Ness A R, Bishop N J et al. Association between bone mass and fractures in children: a prospective cohort study.  J Bone Miner Res. 2006;  21 1489-1495
  • 6 Clark E M, Tobias J H, Ness A R. Association between bone density and fractures in children: a systematic review and meta-analysis.  Pediatrics. 2006;  117 e291-297
  • 7 Engelbert R H, Uiterwaal C S, Gerver W J et al. Osteogenesis imperfecta in childhood: impairment and disability. A prospective study with 4-year follow-up.  Arch Phys Med Rehabil. 2004;  85 772-778
  • 8 Flynn J, Foley S, Jones G. Can BMD Assessed by DXA at Age 8 Predict Fracture Risk in Boys and Girls During Puberty? An Eight-Year Prospective Study.  J Bone Miner Res. 2007;  22 1463-1467
  • 9 Gatti D, Antoniazzi F, Prizzi R et al. Intravenous neridronate in children with osteogenesis imperfecta: a randomized controlled study.  J Bone Miner Res. 2005;  20 758-763
  • 10 Glorieux F H, Bishop N J, Plotkin H et al. Cyclic administration of pamidronate in children with severe osteogenesis imperfecta.  N Engl J Med. 1998;  339 947-952
  • 11 Hind K, Burrows M. Weight-bearing exer­cise and bone mineral accrual in children and adolescents: a review of controlled trials.  Bone. 2007;  40 14-27
  • 12 Jones I E, Williams S M, Goulding A. Associations of birth weight and length, childhood size, and smoking with bone fractures during growth: evidence from a birth cohort study.  Am J Epidemiol. 2004;  159 343-350
  • 13 Kanis J A, McCloskey E V, Johansson H et al. A reference standard for the description of osteoporosis.  Bone. 2008;  42 467-475
  • 14 Khosla S, Melton L J, Dekutoski M B et al. Incidence of childhood distal forearm fractures over 30 years: a population-based study.  JAMA. 2003;  290 1479-1485
  • 15 Land C, Rauch F, Montpetit K et al. Effect of intravenous pamidronate therapy on functional abilities and level of ambulation in children with osteogenesis imperfecta.  J Pediatr. 2006;  148 456-460
  • 16 Land C, Rauch F, Munns C F et al. Vertebral morphometry in children and adolescents with osteogenesis imperfecta: effect of intravenous pamidronate treatment.  Bone. 2006;  39 901-906
  • 17 Letocha A D, Cintas H L, Troendle J F et al. Controlled trial of pamidronate in children with types III and IV osteogenesis im­perfecta confirms vertebral gains but not short-term functional improvement.  J Bone Miner Res. 2005;  20 977-986
  • 18 Manias K, McCabe D, Bishop N. Fractures and recurrent fractures in children; varying effects of environmental factors as well as bone size and mass.  Bone. 2006;  39 652-657
  • 19 Munns C F, Rauch F, Travers R et al. Effects of intravenous pamidronate treatment in infants with osteogenesis imperfecta: ­clin­i­cal and histomorphometric outcome.  J Bone Miner Res. 2005;  20 1235-1243
  • 20 Petit M A, Beck T J, Hughes J M et al. ­Proximal femur mechanical adaptation to weight gain in late adolescence: a six-year longitudinal study.  J Bone Miner Res. 2008;  23 180-188
  • 21 Rauch F, Glorieux F H. Osteogenesis imperfecta.  Lancet. 2004;  363 1377-1385
  • 22 Rauch F, Neu C, Manz F et al. The devel­opment of metaphyseal cortex--implications for distal radius fractures during growth.  J Bone Miner Res. 2001;  16 1547-1555
  • 23 Rauch F, Plotkin H, DiMeglio L et al. Fracture prediction and the definition of osteoporosis in children and adolescents: the ISCD 2007 Pediatric Official Positions.  J Clin Densitom. 2008;  11 22-28
  • 24 Rauch F, Plotkin H, Zeitlin L et al. Bone mass, size, and density in children and adolescents with osteogenesis imperfecta: effect of intravenous pamidronate therapy.  J Bone Miner Res. 2003;  18 610-614
  • 25 Rauch F, Travers R, Plotkin H et al. The ­effects of intravenous pamidronate on the bone tissue of children and adolescents with osteogenesis imperfecta.  J Clin Invest. 2002;  110 1293-1299
  • 26 Schoenau E, Neu C M, Beck B et al. Bone mineral content per muscle cross-sec­tional area as an index of the functional muscle-bone unit.  J Bone Miner Res. 2002;  17 1095-1101
  • 27 Schoenau E, Neu C M, Mokov E et al. Influence of puberty on muscle area and cortical bone area of the forearm in boys and girls.  J Clin Endocrinol Metab. 2000;  85 1095-1098
  • 28 Schoenau E, Neu C M, Rauch F et al. The development of bone strength at the proximal radius during childhood and adolescence.  J Clin Endocrinol Metab. 2001;  86 613-618
  • 29 Specker B L, Johannsen N, Binkley T et al. Total body bone mineral content and tibial cortical bone measures in preschool children.  J Bone Miner Res. 2001;  16 2298-2305

Korrespondenzadresse

Dr. R.  BeccardMPH

Klinik und Poliklinik für Kinderheilkunde · Universität zu Köln

Kerpener Str. 62

50924 Köln

Phone: 02 21 / 4 78 43 60

Fax: 02 21 / 4 78 34 79

Email: ralf.beccard@uk-koeln.de

    >